Therapies aimed at manipulating the microcirculation require the ability to control angiogenesis, defined as the sprouting of new capillaries from existing vessels. Blocking angiogenesis would be beneficial in many pathologies (e.g. cancer, retinopathies and rheumatoid arthritis). In others (e.g. myocardial infarction, stroke and hypertension), promoting angiogenesis would be desirable. We know that vascular pericytes elongate around endothelial cells (ECs) and are functionally associated with regulating vessel stabilization, vessel diameter and EC proliferation. During angiogenesis, bidirectional pericyte-EC signaling is critical for capillary sprout formation. Observations of pericytes leading capillary sprouts also implicate their role in EC guidance. As such, pericytes have recently emerged as a therapeutic target to promote or inhibit angiogenesis. Advancing our basic understanding of pericytes and developing pericyte-related therapies are challenged, like in many other fields, by questions regarding cell identity. This review article discusses what we know about pericyte phenotypes and the opportunity to advance our understanding by defining the specific pericyte cell populations involved in capillary sprouting.

We have developed a synthetic polymer interface for the long-term self-renewal of human embryonic stem cells (hESCs) in defined media. We successfully cultured hESCs on hydrogel interfaces of aminopropylmethacrylamide (APMAAm) for over 20 passages in chemically-defined mTeSR™ 1 media and demonstrated pluripotency of multiple hESC lines with immunostaining and quantitative RT-PCR studies. Results for hESC proliferation and pluripotency markers were both qualitatively and quantitatively similar to cells cultured on Matrigel™ -coated substrates. Mechanistically, it was resolved that bovine serum albumin (BSA) in the mTeSR™ 1 media was critical for cell adhesion on APMAAm hydrogel interfaces. This study uniquely identified a robust long-term culture surface for the self-renewal of hESCs without the use of biologic coatings (e.g., peptides, proteins, or Matrigel™) in completely chemically-defined media that employed practical culturing techniques amenable to clinical-scale cell expansion.

Cardiac disease is the main cause of death in men and women in México and the U.S.A. When heart muscle suffers an injury, i.e. cardiac infarction, the tissue dies and is replaced by a fibrotic scar that does not allow for normal organ function. To alleviate scar tissue, the objective of this work was to investigate and synthesize polyurethane ureas from polycaprolactone diol, methylene bis(4-cyclohexilisocyanate), and butanediamine with different hard segment contents, characterize them, and prove their biocompatibility by seeding SCA-1+/CD45- cardiac progenitor cells obtained from mice cardiospheres. Ultimately, this work aims to explore how polyurethane urea elastomers can aid in therapeutic cardiac tissue regeneration.

No abstract